Concord Medical Services Holdings to Present at the 28th Annual J.P. Morgan Healthcare Conference

News provided by

Concord Medical Services Holdings Limited

Jan 04, 2010, 08:30 ET

BEIJING , Jan. 4 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited (NYSE: CCM) ("CMS" or "the Company"), operator of the largest network of radiotherapy and diagnostic imaging centers in China in terms of revenues and the total number of centers in operation in 2008, announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference, to be held January 11-14, 2010 at the Westin St. Francis Hotel in San Francisco .

Dr. Jianyu Yang , Chief Executive Officer and President of CMS, Mr. Steve Sun , Chief Financial Officer, and Mr. Boxun Zhang, Corporate Vice President, are scheduled to present from 4:00 pm PST to 4:30 pm PST on Wednesday, January 13, 2010 and will be available to meet with investors throughout the day.

For more details, please contact your J.P. Morgan institutional sales representative.

About Concord Medical Services Holdings Limited

CMS operates China's largest network of radiotherapy and diagnostic imaging centers in terms of revenues and the total number of centers in operation in 2008. Since its establishment, CMS has been committed to building an extensive network of radiotherapy and diagnostic imaging centers in China that employ advanced medical technology to sustain lives and reduce suffering. Today, the Company operates a network of more than 80 centers spanning 36 cities and 21 provinces and administrative regions in China .

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties that could cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the SEC, including its registration statement on Form F-1, as amended from time to time. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

    For more information, please contact:

     ICR, Inc.

      In the U.S.:
      Ashley M. Ammon
      Phone: +1-646-277-1227

      In China:
      Michael Tieu
      Phone: +86-10-6599-7968
      Email: [email protected]

SOURCE Concord Medical Services Holdings Limited